Moderna said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company to report results that far exceed expectations.
Ciara Lee reports
Managing Vaccine Expectations
KIMT
The news about two covid-19 vaccines has been absolutely remarkable
